February 29th, 2024
Advancing American Freedom led an amicus brief with over 30 other amici on the FDA’S peeling back of safety protocols and the doubtful approval standards of mifepristone, an abortion drug.
“The Biden administration has prioritized abortion absolutism over safety when approving drugs and cutting out physicians supervision to make abortions more frequent in the wake of the Dobbs decision,” said J. Marc Wheat, AAF General Counsel. “The FDA’s decades-long avoidance of public review must end. The Court must not defer to the FDA’s interpretation, but should exercise independent judgement and recognize the FDA’s expansion of power that was not granted in the Constitution.”
Read the full amicus brief here.
